Arcadia Biosciences (RKDA) Assets Average (2015 - 2025)

Arcadia Biosciences has reported Assets Average for 11 years, with the latest figure at $7.6 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average fell 47.39% year-over-year to $7.6 million; the trailing twelve-month figure through Dec 2025 stood at $7.6 million (down 47.39% YoY), and the FY2025 full-year result was $10.0 million, down 39.61% from the prior year.
• Assets Average for Q4 2025 stood at $7.6 million, down from $8.2 million in the prior quarter.
• The five-year high for Assets Average was $70.8 million in Q2 2021, with the low at $7.6 million in Q4 2025.
• Historically, Assets Average has averaged $30.0 million across 5 years, with a median of $26.9 million in 2023.
• Annual changes were most pronounced in 2021 — Assets Average jumped 102.21% — and 2025, when it tumbled 49.79%.
• Arcadia Biosciences' Assets Average stood at $51.6 million in 2021, then slumped by 38.54% to $31.7 million in 2022, then tumbled by 31.9% to $21.6 million in 2023, then plunged by 33.39% to $14.4 million in 2024, then tumbled by 47.39% to $7.6 million in 2025.
• The last three Assets Average figures came in at $7.6 million (Q4 2025), $8.2 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.